European Association of Nuclear Medicine: Prostate cancer patients who are resistant to hormone treatment used to have a poor prognosis. Until recently, the diagnostic and therapeutic possibilities had been limited, but now innovative developments in nuclear medicine imaging and therapy open up promising pathways. Novel substances used with PET/CT (positron-emission tomography combined with computed tomography) not only allow for better diagnosis but also offer treatment options where other therapies have failed.
Latest from John Shanahan
- Enemies of the Earth - FoE, Greenpeace (Michael Shellenberger) USofA South Korea
- Test Newsletter 2017 # 1
- Coal can offset fuel losses caused by hurricanes by (Clinton Crackel) USofA
- Thorium molten salt reactors - to CA energy commission 6 19 13 (Walter Horsting) USofA
- Mankind's contribution to a more beautiful world (John Shanahan) USofA